Archived Myocardial and Pericardial Diseases Recommended Reading

Access the Working Group homepage

Myocarditis 2018

• Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-analysis JAMA Oncol. 2018 Sep 13. doi: 10.1001/jamaoncol.2018.3923
• Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting System Int J Cardiol. 2018 Sep 14. pii: S0167-5273(17)37685-4. doi: 10.1016/j.ijcard.2018.09.054

• Arrhythmogenic right ventricular cardiomyopathy as a hidden cause of paediatric myocarditis presentation. Int J Cardiol. 2018 Nov 15;271:113-114. doi: 10.1016/j.ijcard.2018.06.117.

• Myocarditis and cardiomyopathy. Current Opinion in Cardiology. Buggey J, ElAamm CA. 2018 Mar 9. doi: 10.1097/HCO.0000000000000514. [Epub ahead of print]

• Viral myocarditis: a prime example for endomyocardial biopsy-guided diagnosis and therapy. Current Opinion in Cardiology. Publish Ahead of Print. Van Linthout S, Tschöpe C. 2018 Mar 9; DOI: 10.1097/HCO.0000000000000515

• Novel insights in HFpEF, cardiomyopathies, and myocarditis. Lüscher TF. Eur Heart J. 2018 Mar 7;39(10):819-822. doi: 10.1093/eurheartj/ehy105

• Still poor prognosis for patients with giant cell myocarditis in the era of temporary mechanical circulatory supports. Ammirati E, Camici PG. Int J Cardiol. 2018 Feb 15;253:122-123. doi: 10.1016/j.ijcard.2017.10.124

• Fulminant giant-cell myocarditis on mechanical circulatory support: Management and outcomes of a French multicentre cohort. Montero S, Aissaoui N, Tadié JM, Bizouarn P, Scherrer V, Persichini R, Delmas C, Rolle F, Besnier E, Le Guyader A, Combes A, Schmidt M. Int J Cardiol. 2018 Feb 15;253:105-112. doi: 10.1016/j.ijcard.2017.10.053

• The immunoproteasome-specific inhibitor ONX 0914 reverses susceptibility to acute viral myocarditis. Althof N, Goetzke CC, Kespohl M, Voss K, Heuser A, Pinkert S, Kaya Z, Klingel K, Beling A. EMBO Mol Med. 2018 Jan 2. pii: e8089. doi: 10.15252/emmm.201708089

Cardiomyopathies 2018

• Diagnosis and Management of Chagas Cardiomyopathy in the United States Curr Cardiol Rep. 2018 Oct 11;20(12):131. doi: 10.1007/s11886-018-1077-5
• Association of Variants in BAG3 With Cardiomyopathy Outcomes in African American Individuals. JAMA Cardiol. 2018 Oct 1;3(10):929-938. doi: 10.1001/jamacardio.2018.2541
• Cardiomyopathy phenotypes in human-induced pluripotent stem cell-derived cardiomyocytes-a systematic review Arch. 2018 Oct 15. doi: 10.1007/s00424-018-2214-0

• On the Road from Gene to Therapy in Inherited Cardiomyopathies. Heart Failure Clinics. Limongelli G, Bossone E, Elliott PM, Day SM. 2018 Apr;14(2):xi-xv. doi: 10.1016/j.hfc.2018.01.003

• Genetic Infiltrative Cardiomyopathies. Heart Failure Clinics. Sweet ME, Mestroni L, Taylor MRG. 2018 Apr;14(2):215-224. doi: 10.1016/j.hfc.2017.12.003

• Diagnostic Criteria, Genetics, and Molecular Basis of Arrhythmogenic Cardiomyopathy. Heart Failure Clinics. Basso C, Pilichou K, Bauce B, Corrado D, Thiene G. 2018 Apr;14(2):201-213. doi: 10.1016/j.hfc.2018.01.002

• Prophylactic use of the implantable cardioverter-defibrillator and its effect on the long-term survival, cardiovascular and sudden cardiac death in nonischemic cardiomyopathy patients-a systematic review and meta-analysis. Siddiqui WJ, Aggarwal S, Rafique M, Singh S, Kutalek S, Eisen HJ. Heart Fail Rev. 2018 Jan 30. doi: 10.1007/s10741-018-9671-6. [Epub ahead of print] Review

• Does Sport Participation Worsen the Clinical Course of Hypertrophic Cardiomyopathy? Clinical Outcome of Hypertrophic Cardiomyopathy in Athletes. Pelliccia A, Lemme E, Maestrini V, Di Paolo FM, Pisicchio C, Di Gioia G, Caselli S. Circulation. 2018 Jan 30;137(5):531-533. doi: 10.1161/CIRCULATIONAHA.117.031725. No abstract available

• Exercise and Hypertrophic Cardiomyopathy: Time for a Change of Heart. Saberi S, Day SM. Circulation. 2018 Jan 30;137(5):419-421. doi: 10.1161/CIRCULATIONAHA.117.029989

Pericardial Diseases 2018

• Outcomes of idiopathic chronic large pericardial effusion

  Heart. 2018 Oct 1. pii: heartjnl-2018-313532. doi: 10.1136/heartjnl-2018-313532. [Epub ahead of print]

• Myocardial involvement in patients with acute idiopathic pericarditis: Back to basics Int J Cardiol. 2018 Nov 1;270:200-201. doi: 10.1016/j.ijcard.2018.07.102. Epub 2018 Jul 25
• Purulent pericarditis: a rare cause for pericardial effusions in a patient with chronic kidney disease Intern Med J. 2018 Aug;48(8):1004-1005. doi: 10.1111/imj.13981
• Recurrent Pericarditis: Is Immunotherapy the Answer? Azrielant S, Shoenfeld Y, Adler Y. Isr Med Assoc J. 2018 Mar;20(3):190-191). PMID: 29527860

• Incidence and Prognosis of Pericarditis After ST-Elevation Myocardial Infarction (from the Acute Coronary Syndrome Israeli Survey 2000 to 2013 Registry Database). Lador A, Hasdai D, Mager A, Porter A, Goldenberg I, Shlomo N, Vorobeichik D, Beigel R, Kornowski R, Iakobishvili Z. Am J Cardiol. 2017 Dec 23. pii: S0002-9149(17)31920-3. doi: 10.1016/j.amjcard.2017.12.006

• The role of colchicine in pericardial syndromes. Lazaros G, Imazio M, Brucato A, Vlachopoulos C, Lazarou E, Vassilopoulos D, Tousoulis D. Curr Pharm Des. 2018 Jan 15. doi: 10.2174/1381612824666180116101823. [Epub ahead of print]

• Constrictive pericarditis: diagnosis, management and clinical outcomes. Welch TD. Heart. 2017 Nov 25. pii: heartjnl-2017-311683. doi: 10.1136/heartjnl-2017-311683. [Epub ahead of print] Review.

Cardiomyopathies 2017

• TranslatiOnal Registry for CardiomyopatHies (TORCH) - rationale and first results. Seyler C, Meder B, Weis T, Schwaneberg T, Weitmann K, Hoffmann W, Katus HA, Dösch A. ESC Heart Fail. 2017 Aug;4(3):209-215. doi: 10.1002/ehf2.12145.

• Epigenome-Wide Association Study Identifies Cardiac Gene Patterning and A Novel Class of Biomarkers for Heart Failure. Meder B1, Haas J1, Sedaghat-Hamedani F1, Kayvanpour E1, Frese K1, Lai A2, Nietsch R2, Scheiner C2, Mester S2, Martins Bordalo D2, Amr A2, Dietrich C3, Pils D4, Siede D5, Hund H2, Bauer AS6, Holzer DB2, Ruhparwar A7, Mueller-Hennessen M2, Weichenhan D8, Plass C8, Weis TM1, Backs J5, Wuerstle ML3, Keller A9, Katus HA10, Posch AE3. Circulation. 2017 Aug 24. pii: CIRCULATIONAHA.117.027355. doi: 10.1161/CIRCULATIONAHA.117.027355. [Epub ahead of print]

• Role of Genetic Testing in Inherited Cardiovascular Disease: A Review. Cirino AL, Harris S, Lakdawala NK, Michels M, Olivotto I, Day SM, Abrams DJ, Charron P, Caleshu C, Semsarian C, Ingles J, Rakowski H, Judge DP, Ho CY. JAMA Cardiol. 2017 Aug 9. doi: 10.1001/jamacardio.2017.2352. [Epub ahead of print]

• Outcome predictors in dilated cardiomyopathy or myocarditis. Kuethe F, Franz M, Jung C, Porrmann C, Reinbothe F, Schlattmann P, Egerer R, Mall G. Eur J Clin Invest. 2017 Jul;47(7):513-523. doi: 10.1111/eci.12772. Epub 2017 Jun 26.

• Clinical Features, Diagnosis, and Management of Patients With Anderson-Fabry Cardiomyopathy. Yogasundaram H, Kim D, Oudit O, Thompson RB, Weidemann F, Oudit GY. Can J Cardiol. 2017 Jul;33(7):883-897. doi: 10.1016/j.cjca.2017.04.015. Epub 2017 May 4. Review.

• Therapeutic Strategies Targeting Inherited Cardiomyopathies. Varian K, Tang WHW. Curr Heart Fail Rep. 2017 Jun 28. doi: 10.1007/s11897-017-0346-8. [Epub ahead of print] Review

• The Burden of Early Phenotypes and the Influence of Wall Thickness in Hypertrophic Cardiomyopathy Mutation Carriers: Findings From the HCMNet Study. Ho CY, Day SM, Colan SD, Russell MW, Towbin JA, Sherrid MV, Canter CE, Jefferies JL, Murphy AM, Cirino AL, Abraham TP, Taylor M, Mestroni L, Bluemke DA, Jarolim P, Shi L, Sleeper LA, Seidman CE, Orav EJ; HCMNet Investigators. JAMA Cardiol. 2017 Feb 22.
  doi: 10.1001/jamacardio.2016.5670.

• Assessing the Phenotypic Burden of Preclinical Sarcomeric Hypertrophic Cardiomyopathy-New Assessments to Guide Diagnosis and Management. Tardiff JC. JAMA Cardiol. 2017 Feb 22. doi: 10.1001/jamacardio.2016.5677

• Inhibition of miR-208b improves cardiac function in titin-based dilated cardiomyopathy.
  Zhou Q, Schötterl S, Backes D, Brunner E, Hahn JK, Ionesi E, Aidery P, Sticht C, Labeit S, Kandolf R, Gawaz M, Gramlich M. Int J Cardiol. 2016 Dec 28. pii: S0167-5273(16)34822-7. doi: 10.1016/j.ijcard.2016.12.171

• Genome-wide association study in takotsubo syndrome - Preliminary results and future directions.
  Eitel I, Moeller C, Munz M, Stiermaier T, Meitinger T, Thiele H, Erdmann J. Int J Cardiol. 2017 Jan 15. pii: S0167-5273(16)33040-6. doi: 10.1016/j.ijcard.2017.01.093

• Serelaxin treatment promotes adaptive hypertrophy but does not prevent heart failure in experimental peripartum cardiomyopathy.
  Nonhoff J, Ricke-Hoch M, Mueller M, Stapel B, Pfeffer T, Kasten M, Scherr M, von Kaisenberg C, Bauersachs J, Haghikia A, Hilfiker-Kleiner D. Cardiovasc Res. 2017 Jan 20. pii: cvw245. doi: 10.1093/cvr/cvw245

Myocarditis 2017

• Beating, Fast and Slow. Jani SM, Nallamothu BK, Cooper LT, Smith A, Fazel R. N Engl J Med. 2017 Jul 6;377(1):72-78. doi: 10.1056/NEJMcps1608688.

• Survival and Left Ventricular Function Changes in Fulminant Versus Nonfulminant Acute Myocarditis. Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino M, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Circulation. 2017 Aug 8;136(6):529-545. doi: 10.1161/CIRCULATIONAHA.117.026386. Epub 2017 Jun 2.

• Myocarditis: A Clinical Overview. Caforio ALP, Malipiero G, Marcolongo R, Iliceto S. Curr Cardiol Rep. 2017 Jul;19(7):63. doi: 10.1007/s11886-017-0870-x. Review

• Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis. Kaese S, Larbig R, Rohrbeck M, Frommeyer G, Dechering D, Olligs J, Schönhofer-Merl S, Wessely R, Klingel K, Seebohm G, Eckardt L. PLoS One. 2017 Jun 23;12(6):e0180029. doi: 10.1371/journal.pone.0180029. eCollection 2017

• Differentiation of Takotsubo syndrome from infarct-like myocarditis. Stiermaier T, Lurz P. Int J Cardiol. 2017 Sep 1;242:44. doi: 10.1016/j.ijcard.2017.05.020

• Survival and Left Ventricular Function Changes in Fulminant Versus Non-Fulminant Acute Myocarditis. Ammirati E, Cipriani M, Lilliu M, Sormani P, Varrenti M, Raineri C, Petrella D, Garascia A, Pedrotti P, Roghi A, Bonacina E, Moreo A, Bottiroli M, Gagliardone MP, Mondino MG, Ghio S, Totaro R, Turazza FM, Russo CF, Oliva F, Camici PG, Frigerio M. Circulation. 2017 Jun 2. pii: CIRCULATIONAHA.117.026386. doi: 10.1161/CIRCULATIONAHA.117.026386. [Epub ahead of print]

• Detection and Monitoring of Acute Myocarditis Applying Quantitative Cardiovascular Magnetic Resonance.
  von Knobelsdorff-Brenkenhoff F, Schüler J, Dogangüzel S, Dieringer MA, Rudolph A, Greiser A, Kellman P, Schulz-Menger J. Circ Cardiovasc Imaging. 2017 Feb;10(2). pii: e005242. doi: 10.1161/CIRCIMAGING.116.005242

• Why Edema Is a Matter of the Heart. Friedrich MG. Circ Cardiovasc Imaging. 2017 Feb;10(2).
  pii: e006062. doi: 10.1161/CIRCIMAGING.117.006062.

• Manifestations of Lyme carditis.
  Kostić T, Momčilović S, Perišić ZD, Apostolović SR, Cvetković J, Jovanović A, Barać A, Šalinger-Martinović S, Tasić-Otašević S. Int J Cardiol. 2016 Dec 27. pii: S0167-5273(16)34820-3. doi: 10.1016/j.ijcard.2016.12.169

• Biventricular endomyocardial biopsy in patients with suspected myocarditis: Feasibility, complication rate and additional diagnostic value.
  Stiermaier T, Föhrenbach F, Klingel K, Kandolf R, Boudriot E, Sandri M, Linke A, Rommel KP, Desch S, Schuler G, Thiele H, Lurz P. Int J Cardiol. 2016 Dec 21. pii: S0167-5273(16)34594-6. doi: 10.1016/j.ijcard.2016.12.103

• Is colchicine really harmful in viral myocarditis?
  Maestroni S, Imazio M, Valenti A, Assolari A, Brucato A. Int J Cardiol. 2017 Feb 15;229:42. doi:10.1016/j.ijcard.2016.10.031.

Pericardial Diseases 2017

• Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality. Søgaard KK, Farkas DK, Ehrenstein V, Bhaskaran K, Bøtker HE, Sørensen HT. Circulation. 2017 Jun 29. pii: CIRCULATIONAHA.116.024041. doi: 10.1161/CIRCULATIONAHA.116.024041. [Epub ahead of print]

• Acute and Recurrent Pericarditis: Still Idiopathic? Brucato A, Valenti A, Maisch B. J Am Coll Cardiol. 2017 Jun 6;69(22):2775. doi: 10.1016/j.jacc.2017.02.072. No abstract available.

• Uremic pericarditis, pericardial effusion, and constrictive pericarditis in end-stage renal disease: Insights and pathophysiology. Rehman KA, Betancor J, Xu B, Kumar A, Rivas CG, Sato K, Wong LP, Asher CR, Klein AL. Clin Cardiol. 2017 Sep 5. doi: 10.1002/clc.22770. [Epub ahead of print] Review.

• Pericarditis as a Marker of Occult Cancer and a Prognostic Factor for Cancer Mortality. Søgaard KK, Farkas DK, Ehrenstein V, Bhaskaran K, Bøtker HE, Sørensen HT. Circulation. 2017 Jun 29. pii: CIRCULATIONAHA.116.024041. doi: 10.1161/CIRCULATIONAHA.116.024041. [Epub ahead of print]

• Interleukin-1 Blockade for the Treatment of Pericarditis. Buckley L, Viscusi MM, Van Tassell B, Abbate A. Eur Heart J Cardiovasc Pharmacother. 2017 Jun 19. doi: 10.1093/ehjcvp/pvx018. [Epub ahead of print]

• Surgical Treatment of Constrictive Pericarditis. Depboylu BC, Mootoosamy P, Vistarini N, Testuz A, El-Hamamsy I, Cikirikcioglu M. Tex Heart Inst J. 2017 Apr 1;44(2):101-106. doi: 10.14503/THIJ-16-5772. eCollection 2017 Apr. Review.

• Fluorodeoxyglucose PET/CT Predicts Response to Steroid Therapy in Constrictive Pericarditis.
  Chang SA, Choi JY, Kim EK, Hyun SH, Jang SY, Choi JO, Park SJ, Lee SC, Park SW, Oh JK. J Am Coll Cardiol. 2017 Feb 14;69(6):750-752. doi: 10.1016/j.jacc.2016.11.059.

• Recurrent pericarditis. Imazio M, Battaglia A, Gaido L, Gaita F. Rev Med Interne. 2017 Feb 6.
  pii: S0248-8663(16)31045-1. doi: 10.1016/j.revmed.2016.12.006

• Resolution of pericardial constriction with anakinra; possible role of C reactive protein.
  Brucato A, Valenti A, Assolari A, Calabrese A, Imazio M, Martini A. Int J Cardiol. 2016 Dec 1. pii: S0167-5273(16)34013-X. doi: 10.1016/j.ijcard.2016.11.312

• Recent advances in the management of pericardial diseases.
  Celentani D, Di Cuia M, Imazio M, Gaita F. Hosp Pract (1995). 2016 Dec;44(5):266-273.

Cardiomyopathies 2016

• Ohlow MA, Brunelli M, Schreiber M, Lauer B.
  Therapeutic effect of immunoadsorption and subsequent immunoglobulin substitution in patients with dilated cardiomyopathy: Results from the observational prospective Bad Berka Registry
  J Cardiol. 2016 Nov 24. pii: S0914-5087(16)30161-7. doi: 10.1016/j.jjcc.2016.07.014.
• Dalin MG, Engström PG, Ivarsson EG, Unneberg P, Light S, Schaufelberger M, Gilljam T, Andersson B, Bergo MO. Massive parallel sequencing questions the pathogenic role of missense variants in dilated cardiomyopathy 
  Int J Cardiol. 2016 Nov 9; 228:742-748. doi: 10.1016/j.ijcard.2016.11.066. [Epub ahead of print]
• Kumar S, Baldinger SH, Gandjbakhch E, Maury P, Sellal JM, Androulakis AF, Waintraub X, Charron P, Rollin A, Richard P, Stevenson WG, Macintyre CJ, Ho CY, Thompson T, Vohra JK, Kalman JM, Zeppenfeld K, Sacher F, Tedrow UB, Lakdawala NK.
  Long-Term Arrhythmic and Nonarrhythmic Outcomes of Lamin A/C Mutation Carriers.
  J Am Coll Cardiol. 2016 Nov 29; 68(21):2299-2307. doi: 10.1016/j.jacc.2016.08.058
• Templin C, Ghadri JR, Napp LC.
  Takotsubo (Stress) Cardiomyopathy
  N Engl J Med. 2015 Dec 31;373(27):2689-91.

• Gertz MA, Benson MD, Dyck PJ, Grogan M, Coelho T, Cruz M, Berk JL,Plante-Bordeneuve V, Schmidt HH, Merlini G. Diagnosis, Prognosis, and Therapy of Transthyretin Amyloidosis.
  J Am Coll Cardiol. 2015 Dec 1;66(21):2451-66.
• Maron BJ, Udelson JE, Bonow RO, Nishimura RA, Ackerman MJ, Estes NA 3rd, Cooper LT Jr, Link MS, Maron MS.
  Eligibility and Disqualification Recommendations for Competitive Athletes With Cardiovascular Abnormalities: Task Force 3: Hypertrophic Cardiomyopathy, Arrhythmogenic Right Ventricular Cardiomyopathy and Other Cardiomyopathies, and Myocarditis: A Scientific Statement From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2015 Dec 1;66(21):2362-71.
• Behrens I, Basit S, Lykke JA, Ranthe MF, Wohlfahrt J, Bundgaard H, Melbye M,Boyd HA.
  Association Between Hypertensive Disorders of Pregnancy and Later Risk of Cardiomyopathy.
  JAMA. 2016 Mar 8;315(10):1026-33.
• Green EM, Wakimoto H, Anderson RL, Evanchik MJ, Gorham JM, Harrison BC, Henze M, Kawas R, Oslob JD, Rodriguez HM, Song Y, Wan W, Leinwand LA, Spudich JA, McDowell RS, Seidman JG, Seidman CE.
  A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice.
  Science. 2016 Feb 5;351(6273):617-21.
• Rooms I, Dujardin K, De Sutter J.
  Non-compaction cardiomyopathy: a genetically and clinically heterogeneous disorder.
  Acta Cardiol. 2015 Dec;70(6):625-31.
• Hinojar R, Varma N, Child N, Goodman B, Jabbour A, Yu CY, Gebker R, Doltra A, Kelle S, Khan S, Rogers T, Arroyo Ucar E, Cummins C, Carr-White G, Nagel E, Puntmann VO.
  T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
  Circ Cardiovasc Imaging. 2015 Dec;8(12).

Myocarditis 2016

• Heymans S, Eriksson U, Lehtonen J, Cooper LT Jr.
  The Quest for New Approaches in Myocarditis and Inflammatory Cardiomyopathy
  J Am Coll Cardiol. 2016 Nov 29; 68(21):2348-2364. doi: 10.1016/j.jacc.2016.09.937. Review
• Johnson DB, Balko JM, Compton ML, Chalkias S, Gorham J, Xu Y, Hicks M, Puzanov I, Alexander MR, Bloomer TL, Becker JR, Slosky DA, Phillips EJ, Pilkinton MA, Craig-Owens L, Kola N, Plautz G, Reshef DS, Deutsch JS, Deering RP, Olenchock BA, Lichtman AH, Roden DM, Seidman CE, Koralnik IJ, Seidman JG, Hoffman RD, Taube JM, Diaz LA Jr, Anders RA, Sosman JA, Moslehi JJ.
  Fulminant Myocarditis with Combination Immune Checkpoint Blockade
  N Engl J Med. 2016 Nov 3; 375(18):1749-1755
• Sinagra G, Anzini M, Pereira NL, Bussani R, Finocchiaro G, Bartunek J, Merlo M.
  Myocarditis in Clinical Practice. Mayo Clin Proc
  2016 Sep; 91(9):1256-66.doi: 10.1016/j.mayocp.2016.05.013. Review
• Escher F, Tschöepe C, Lassner D, Schultheiss HP.
  Myocarditis and inflammatory cardiomyopathy: from diagnosis to treatment.
  Turk Kardiyol Dern Ars. 2015 Dec;43(8):739-48. doi: 10.5543/tkda.2015.47750. PubMed PMID: 26717340.
• Toussaint M, Gilles RJ, Azzabou N, Marty B, Vignaud A, Greiser A, Carlier PG.
  Characterization of Benign Myocarditis Using Quantitative Delayed-Enhancement Imaging Based on Molli T1 Mapping.
  Medicine (Baltimore). 2015 Oct;94(43):e1868.
• Kiselnik D, Wolak A, Abu-Shakra M, Basok A.
  Acute Myocarditis and Myopathy as Presenting Manifestations of Human Immunodeficiency Virus Infection.
  Isr Med Assoc J. 2015 Aug;17(8):524-5. PubMed PMID: 26394500.
• Cox AT, White S, Ayalew Y, Boos C, Haworth K, McKenna WJ.
  Myocarditis and the military patient.
  J R Army Med Corps. 2015 Sep;161(3):275-82.

Pericardial Disease 2016

• Brucato A, Imazio M, Gattorno M, Lazaros G, Maestroni S, Carraro M, Finetti M, Cumetti D, Carobbio A, Ruperto N, Marcolongo R, Lorini M, Rimini A, Valenti A, Erre GL, Sormani MP, Belli R, Gaita F, Martini A.
  Effect of Anakinra on Recurrent Pericarditis Among Patients With Colchicine Resistance and Corticosteroid Dependence: The AIRTRIP Randomized Clinical Trial
  JAMA. 2016 Nov 8; 316(18):1906-1912. doi: 10.1001/jama.2016.15826
• Imazio M, Gribaudo E, Gaita F. Recurrent Pericarditis. Prog Cardiovasc Dis. 2016 Oct 7. pii: S0033-0620(16)30109-8. doi: 10.1016/j.pcad.2016.10.001. [Epub ahead of print] Review.
• Lazaros G, Imazio M, Brucato A, Tousoulis D.
  Untying the Gordian Knot of Pericardial Diseases. A Pragmatic Approach.  Hellenic J Cardiol. 2016 Nov 25.
  pii: S1109-9666(16)30305-0. doi: 10.1016/j.hjc.2016.11.024. [Epub ahead of print] Review.
• Schichter-Konfino V, Vadasz Z, Toubi E.
  Recurrent Pericarditis: An Autoinflammatory Disease?
  Isr Med Assoc J. 2015 Dec;17(12):783-4.
• Chhabra L, Bhattad VB, Memon S, Spodick DH.
  Arrhythmogenic Potential of Acute Idiopathic Pericarditis.
  Card Electrophysiol Clin. 2015 Dec;7(4):xix-xx.
• Patel H, Patel C, Soni M, Patel A, Banda V.
  Acute Primary Pneumococcal Purulent Pericarditis With Cardiac Tamponade: A Case Report and Literature Review.
  Medicine (Baltimore). 2015 Oct;94(41):e1709.
• Alexandre J, Fedrizzi S, Debruyne D, Coquerel A, Le Boisselier R.
  Synthetic cannabinoid (K2) use in pediatric patients and cardiovascular events: A place for pericarditis and myopericarditis?
  J Pediatr. 2015 Dec;167(6):1454.
• Rodrigues P, Martins D, Oliveira F, Luz A, Palma P, Torres S.
  Purulent pericarditis: think outside the box.
  Acta Cardiol. 2015 Dec;70(6):737-8.